LIPONIL TABLET

 ‘A Master Lipid Nullifier’

Liponil tablet is an Ayurvedic  Proprietary Medicine from Vaidyaratnam Oushadhasala . It is used for the treatment of  dyslipidemia. It is a polyherbal formulation which contains 8 drugs- Vrkshamla, Guggulu, Pippali, Maricha, Sunti, Rasona, Upakunchika and Arjuna.

Indications : Dyslipidemia

Experiential wisdom : Dyslipidemia

Dosage  : 1-2 tablets after food or as directed by the physician.

Ingredients :

Each tablet prepared out of :

Cumulative Pharmacological properties of the  formulation:

Rasa: Thiktha madhura kashaya katu

Virya: Ushna

Vipaka: Katu

Cumulative Pharmacological action of the  formulation:

Doshakarma: Tridoshahara,especially kaphahara

Dhathukarma :Medhohara

Agnikarma: Deepana,pachana

Anyakarma: Vibndhagna, hrdrogaghna, sulagna, sophagna, avaranagna.

Phytoconstituents used in :

Hydroxycitric acid (Garcinia gummi-gatta) , Guggulsterone Z& E (Commiphora mukul) , piperine (Piper longum) , Polyphenols, 6-shogaol, 6-gingerol, zingerone (Zingiber officinale), Allicin (Allium sativum), Thymoquinone ,Volatile oil, Nigelline(Nigella sativa) , arjunic acid, arjunolic acid, arjunin, arjunoglycoside , CoQ10 (Terminalia arjuna) .

Complications of dyslipidemia :

Pharmacodynamics :

Dyslipidemia is known to promote atherosclerosis. It is a complex disease and is a major risk factor for adverse cardiovascular events. High levels of low‐density lipoprotein (LDL) and low levels of high‐density lipoprotein (HDL) are associated with myocardial infarction (MI) and stroke.

On analysing this  formula , it shows the following Pharmacological actions.

Nutritional aspects of dyslipidemia

Ayurvedic point of view :

This  formulation is predominant of katu thiktha amla madhura kashaya rasa, Laghu ruksha guna, Ushna virya and Katu vipaka. Acharya Charaka has mentioned rukshana upakrama(a type of management which induces dryness)  as one among the Shad -upakrama and can be  considered as the best for the reduction of increased kapha dosha and medo dhathu. In dyslipidemia , deranged lipid levels are found probably as a result of vitiation of medo dhathu. Vrkshamla and guggulu , the main ingredient in this formulation are predominant of ruksha guna. Acharya Vagbhata  has mentioned that  guggulu is best for reducing medas( excess fat in the body) , vata and kapha doshas . This formulation is predominant of katu vipaka , which also subsides the kaphadosha. The treatment for dyslipidemia consists of kapha-medohara protocol. Therefore, this formulation helps to decrease excess sneha (unctuousness, oiliness) from the body which is generated by kapha. Katu thiktha rasa acts as kapha samaka.  Guggulu is predominant of thiktha rasa, it acts as lekhana. So it helps to reduce  excessive meda dhathu in the body. Meda is predominant of jala and prithvi mahabhutha . So this formulation predominant of agni and vayu mahabhuta helps to break the samprapthi involved in dyslipidemia.

 

Conclusion:

Bibliography

  1. Deore AB, Sapakal VD, Naikwade NS. Antidiabetic, antihyperlipidemic and renal protective activities of Garcinia indica Linn. Clusiaceae. International Journal of Pharmaceutical Sciences and Drug Research. 2018;10(1):39-45.
  2. Barve K. Garcinol enriched fraction from the fruit rind of Garcinia indica ameliorates atherosclerotic risk factor in diet induced hyperlipidemic C57BL/6 mice. Journal of traditional and complementary medicine. 2021 Mar;11(2):95.
  3. Sarup P, Bala S, Kamboj S. Pharmacology and phytochemistry of oleo-gum resin of Commiphora wightii (Guggulu). Scientifica. 2015 Oct 26;2015.
  4. Ramesh B, Sainath SB, Karuna R, Reddy SS, Manjunatha B, Sudhakara G, Rao BS, Saralakumari D. Effect of Commiphora mukul gum resin on hepatic and renal marker enzymes, lipid peroxidation and antioxidants status in pancreas and heart in fructose fed insulin resistant rats. Beni-Suef University Journal of Basic and Applied Sciences. 2015 Dec 1;4(4):269-78.
  5. Srivastava P. Therapeutic potential of Piper longum L. for disease management-A Review. International Journal of Pharma Sciences. 2014;4(4):692-.
  6. Kesarwani K, Gupta R. Bioavailability enhancers of herbal origin: An overview. Asian Pacific journal of tropical biomedicine. 2013 Apr 1;3(4):253-66.
  7. Zaveri M, Khandhar A, Patel S, Patel A. Chemistry and pharmacology of Piper longum L. International journal of pharmaceutical sciences review and research. 2010 Nov;5(1):67-76.
  8. Analgesic activity of Piper longum Linn. Root, Indian J Exp Biol, 41(6), 2003, 649- 651.
  9. Mao QQ, Xu XY, Cao SY, Gan RY, Corke H, Li HB. Bioactive compounds and bioactivities of ginger (Zingiber officinale Roscoe). Foods. 2019 Jun;8(6):185.
  10. El-Saber Batiha G, Magdy Beshbishy A, G Wasef L, Elewa YH, A Al-Sagan A, El-Hack A, Mohamed E, Taha AE, M Abd-Elhakim Y, Prasad Devkota H. Chemical constituents and pharmacological activities of garlic (Allium sativum L.): A review. Nutrients. 2020 Mar;12(3):872.
  11. Oskouei BG, Abbaspour-Ravasjani S, Musavinejad SJ, Salehzadeh SA, Abdolhosseinzadeh A, Ghahremanzadeh K, Shokouhi B. In vivo evaluation of anti-hyperglycemic, anti-hyperlipidemic and anti-oxidant status of liver and kidney of thymol in STZ-induced diabetic rats. Drug Research. 2019 Jan;69(01):46-52.
  12. Dalli M, Bekkouch O, Azizi SE, Azghar A, Gseyra N, Kim B. Nigella sativa L. Phytochemistry and Pharmacological Activities: A Review (2019–2021). Biomolecules. 2021 ;12(1):20.
  13. Zafar K, Noorul H, Nesar A, Vartika S, Khalid M, Prashant S, Xeeshan A, Zohrameena S. Pharmacological activity of Nigella sativa: A review. World J. Pharm. Sci. 2016;45:234
  14. Amalraj A, Gopi S. Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: a review. Journal of traditional and complementary medicine. 2017 Jan